[Source: NewsWire] – Thermo Fisher Scientific Inc., the world leader in serving science, and Professor Bruno Domon, director of the new Luxembourg Clinical Proteomics unit (LCP), today announced a collaboration to develop workflows that overcome current bottlenecks in biomarker discovery and assay development for clinical proteomics research. The LCP is funded by the Fonds National de la Recherch and is hosted at Public Research Centre for Health (CRP-Santé).
For more information: Thermo Fisher Scientific Collaborates on Clinical Biomarker Research